
Articles
-
4 days ago |
today.westlaw.com | Shinjini Ganguli |Sneha K |Siddhi Mahatole |Maju Samuel
(Reuters) -Louisiana Attorney General Liz Murrill said on Tuesday she had filed three separate lawsuits against CVS for unfair, deceptive and unlawful practices "that have harmed Louisiana patients, independent pharmacies, and the public at large."...
-
4 days ago |
today.westlaw.com | Shinjini Ganguli |Bhanvi Satija |Sneha K |Bill Berkrot
(Reuters) -A review on the use of the preservative thimerosal in vaccines slated to be presented on Thursday to the U.S. Centers for Disease Control and Prevention's outside vaccine committee cites a study that does not exist, the scientist listed as...
-
1 week ago |
today.westlaw.com | Shinjini Ganguli |Sneha K
(Reuters) -The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with national priorities to shorten their review time for a drug application to one to two months from the typical...
-
1 week ago |
japantimes.co.jp | Sriparna Roy |Sneha K
U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments. Through June, U.S. drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData.
-
1 week ago |
today.westlaw.com | Manas Mishra |Sriparna Roy |Sneha K |Bill Berkrot
(Reuters) -U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →